Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Afable Richard, Director. Officer active across 1 company, notably Acelrx Pharmaceuticals INC. Cumulatively, 4 disclosures have been logged. Activity tracked since 17 June 2021. The latest transaction was filed on 10 October 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
4 of 4 declarations
Richard Afable is a Director of ACELRX PHARMACEUTICALS INC. In this role, he participates in the governance and strategy of the company, which specializes in drug development. Richard brings valuable expertise in corporate strategy and product development, contributing to the direction of key decisions for AcelRx.